A Weighted Prognostic Covariate Adjustment Method for Efficient and Powerful Treatment Effect Inferences in Randomized Controlled Trials

• URL: http://arxiv.org/abs/2309.14256v1
• Date: Mon, 25 Sep 2023 16:14:13 GMT
• Title: A Weighted Prognostic Covariate Adjustment Method for Efficient and Powerful Treatment Effect Inferences in Randomized Controlled Trials
• Authors: Alyssa M. Vanderbeek, Anna A. Vidovszky, Jessica L. Ross, Arman Sabbaghi, Jonathan R. Walsh, Charles K. Fisher, the Critical Path for Alzheimer's Disease, the Alzheimer's Disease Neuroimaging Initiative, the European Prevention of Alzheimer's Disease (EPAD) Consortium, the Alzheimer's Disease Cooperative Study
• Abstract summary: A crucial task for a randomized controlled trial (RCT) is to specify a statistical method that can yield an efficient estimator and powerful test for the treatment effect. Training a generative AI algorithm on historical control data enables one to construct a digital twin generator (DTG) for RCT participants. DTG generates a probability distribution for RCT participants' potential control outcome.
• Score: 0.28087862620958753
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: A crucial task for a randomized controlled trial (RCT) is to specify a statistical method that can yield an efficient estimator and powerful test for the treatment effect. A novel and effective strategy to obtain efficient and powerful treatment effect inferences is to incorporate predictions from generative artificial intelligence (AI) algorithms into covariate adjustment for the regression analysis of a RCT. Training a generative AI algorithm on historical control data enables one to construct a digital twin generator (DTG) for RCT participants, which utilizes a participant's baseline covariates to generate a probability distribution for their potential control outcome. Summaries of the probability distribution from the DTG are highly predictive of the trial outcome, and adjusting for these features via regression can thus improve the quality of treatment effect inferences, while satisfying regulatory guidelines on statistical analyses, for a RCT. However, a critical assumption in this strategy is homoskedasticity, or constant variance of the outcome conditional on the covariates. In the case of heteroskedasticity, existing covariate adjustment methods yield inefficient estimators and underpowered tests. We propose to address heteroskedasticity via a weighted prognostic covariate adjustment methodology (Weighted PROCOVA) that adjusts for both the mean and variance of the regression model using information obtained from the DTG. We prove that our method yields unbiased treatment effect estimators, and demonstrate via comprehensive simulation studies and case studies from Alzheimer's disease that it can reduce the variance of the treatment effect estimator, maintain the Type I error rate, and increase the power of the test for the treatment effect from 80% to 85%~90% when the variances from the DTG can explain 5%~10% of the variation in the RCT participants' outcomes.

Related papers

• Prognostic Covariate Adjustment for Logistic Regression in Randomized Controlled Trials [1.5020330976600735]
  We show that prognostic score adjustment can increase the power of the Wald test for the conditional odds ratio under a fixed sample size. We utilize g-computation to expand the scope of prognostic score adjustment to inferences on the marginal risk difference, relative risk, and odds ratio estimands.
  arXiv  Detail & Related papers  (2024-02-29T06:53:16Z)
• Bayesian Prognostic Covariate Adjustment With Additive Mixture Priors [0.3749861135832073]
  We propose a new Bayesian prognostic covariate adjustment methodology, referred to as Bayesian PROCOVA. It is based on generative artificial intelligence (AI) algorithms that construct a digital twin generator (DTG) for RCT participants. The DTG is trained on historical control data and yields a digital twin (DT) probability distribution for each RCT participant's outcome under the control treatment. We establish an efficient Gibbs algorithm for sampling from the posterior distribution, and derive closed-form expressions for the posterior mean and variance of the treatment effect parameter conditional on the weight.
  arXiv  Detail & Related papers  (2023-10-27T10:05:06Z)
• B-Learner: Quasi-Oracle Bounds on Heterogeneous Causal Effects Under Hidden Confounding [51.74479522965712]
  We propose a meta-learner called the B-Learner, which can efficiently learn sharp bounds on the CATE function under limits on hidden confounding. We prove its estimates are valid, sharp, efficient, and have a quasi-oracle property with respect to the constituent estimators under more general conditions than existing methods.
  arXiv  Detail & Related papers  (2023-04-20T18:07:19Z)
• Robust and Agnostic Learning of Conditional Distributional Treatment Effects [62.44901952244514]
  The conditional average treatment effect (CATE) is the best point prediction of individual causal effects. In aggregate analyses, this is usually addressed by measuring distributional treatment effect (DTE) We provide a new robust and model-agnostic methodology for learning the conditional DTE (CDTE) for a wide class of problems.
  arXiv  Detail & Related papers  (2022-05-23T17:40:31Z)
• Assessment of Treatment Effect Estimators for Heavy-Tailed Data [70.72363097550483]
  A central obstacle in the objective assessment of treatment effect (TE) estimators in randomized control trials (RCTs) is the lack of ground truth (or validation set) to test their performance. We provide a novel cross-validation-like methodology to address this challenge. We evaluate our methodology across 709 RCTs implemented in the Amazon supply chain.
  arXiv  Detail & Related papers  (2021-12-14T17:53:01Z)
• Efficient Learning of Optimal Individualized Treatment Rules for Heteroscedastic or Misspecified Treatment-Free Effect Models [3.7311680121118345]
  We propose an Efficient Learning framework for finding an optimal individualized treatment rule (ITR) in the multi-armed treatment setting. We show that the proposed E-Learning is optimal among a regular class of semiparametric estimates that can allow treatment-free effect misspecification.
  arXiv  Detail & Related papers  (2021-09-06T16:11:42Z)
• Bootstrapping Your Own Positive Sample: Contrastive Learning With Electronic Health Record Data [62.29031007761901]
  This paper proposes a novel contrastive regularized clinical classification model. We introduce two unique positive sampling strategies specifically tailored for EHR data. Our framework yields highly competitive experimental results in predicting the mortality risk on real-world COVID-19 EHR data.
  arXiv  Detail & Related papers  (2021-04-07T06:02:04Z)
• Bayesian prognostic covariate adjustment [59.75318183140857]
  Historical data about disease outcomes can be integrated into the analysis of clinical trials in many ways. We build on existing literature that uses prognostic scores from a predictive model to increase the efficiency of treatment effect estimates.
  arXiv  Detail & Related papers  (2020-12-24T05:19:03Z)
• Increasing the efficiency of randomized trial estimates via linear adjustment for a prognostic score [59.75318183140857]
  Estimating causal effects from randomized experiments is central to clinical research. Most methods for historical borrowing achieve reductions in variance by sacrificing strict type-I error rate control.
  arXiv  Detail & Related papers  (2020-12-17T21:10:10Z)
• Estimating heterogeneous survival treatment effect in observational data using machine learning [9.951103976634407]
  Methods for estimating heterogeneous treatment effect in observational data have largely focused on continuous or binary outcomes. Using flexible machine learning methods in the counterfactual framework is a promising approach to address challenges due to complex individual characteristics.
  arXiv  Detail & Related papers  (2020-08-17T01:02:14Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.